Phase Ⅰ Clinical Trial of Gerilimzumab Injection in Healthy Subjects

NCT04178070 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: GB224 2mg
BIOLOGICAL: GB224 5mg
BIOLOGICAL: GB224 10mg
BIOLOGICAL: GB224 15mg
BIOLOGICAL: GB224 20mg
BIOLOGICAL: GB224 30mg
OTHER: Placebo, 2mg
OTHER: Placebo, 5mg
OTHER: Placebo, 10mg
OTHER: Placebo, 15mg
OTHER: Placebo, 20mg
OTHER: Placebo, 30mg

Sponsor

Genor Biopharma Co., Ltd.